Chuay-Yeng Koo

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

Viktoriya D. Nikolova, Chuay-Yeng Koo, Sherif Ibrahim et al. · Carcinogenesis · 2009 · 181 citations

Medicine, Cell Biology, Oncology +14

SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer

Mattaka Khongkow, Yolanda Olmos, Chun Gong et al. · Carcinogenesis · 2013 · 174 citations · Full text

Medicine, Molecular Biology, Oncology +17

Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness <i>via</i> a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism

Sherif Ibrahim, George W. Yip, Christian Stock et al. · International Journal of Cancer · 2012 · 156 citations

Medicine, Cancer Biology, Oncology +13

Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin

Ka-Kei Ho, Victoria A. McGuire, Chuay-Yeng Koo et al. · Journal of Biological Chemistry · 2011 · 144 citations · Full text

Life Sciences, Cell Biology, Oncology +14

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies

Caterina Giacomini, Chuay-Yeng Koo, Natalia Yankova et al. · Acta Neuropathologica Communications · 2018 · 62 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17